Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
企業コードTNDM
会社名Tandem Diabetes Care Inc
上場日Nov 13, 2013
最高経営責任者「CEO」Mr. John F. Sheridan
従業員数2650
証券種類Ordinary Share
決算期末Nov 13
本社所在地12400 High Bluff Drive
都市SAN DIEGO
証券取引所NASDAQ Global Market Consolidated
国United States of America
郵便番号92130
電話番号18583666900
ウェブサイトhttps://www.tandemdiabetes.com/
企業コードTNDM
上場日Nov 13, 2013
最高経営責任者「CEO」Mr. John F. Sheridan
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし